Pav Rishiraj on pharmacovigilance

This GOLD Nugget episode sees Helena reflect on some of the best insights offered by Pav Rishiraj, Director and Head of Pharmacovigilance at Ipsen. She shares some of Pav's thoughts on how the often under-recognised field of pharmacovigilance has changed – particularly its rapid evolution during the COVID-19 pandemic – and its importance as a strategic enabler, as well as Pav's advice on what pharma should do to ensure teams feel valued and integral to the businesses they serve. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: Pav’s full episode: Pharmacovigilance past, present and future https://www.emg-gold.com/post/podcast-pharmacovigilance-past-present-and-future The physics of pharmacovigilance https://www.emg-gold.com/post/the-physics-of-pharmacovigilance

There are no comments yet.

Please log in to write the first comment.